EUVIMEDEUVIMED entdecken
Open Access

Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain

Yoshihiko Fujita, Hiromichi Matsuoka, Yasutaka Chiba, Junji Tsurutani, Takeshi Yoshida, Kiyohiro Sakai, Miki Nakura, Ryo Sakamoto, Chihiro Makimura, Yoichi Ohtake, Kaoru Tanaka, Hidetoshi Hayashi und 9 weitere

Oncology Letters · 04.07.2023 · 26 (2)

DOI: 10.3892/ol.2023.13941 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 04.07.2023. Verfasst von Yoshihiko Fujita und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genome Biology, Kindai University Faculty of Medicine, Osaka 589-8511, Japan. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There have been few studies on predictive biomarkers that may be useful to select the most suitable opioids to optimize therapeutic efficacy in individual patients with cancer pain. We recently investigated the efficacy of morphine and oxycodone using single nucleotide polymorphisms (SNPs) of the catechol-O-methyltransferase (COMT) rs4680 gene as a biomarker (RELIEF study). To explore additional biomarkers that may enable the selection of an appropriate opioid for individual patients with cancer pain, three SNPs were examined: C-C motif chemokine ligand 11 (CCL11; rs17809012), histamine N-methyltransferase (HNMT; rs1050891) and transient receptor potential V1 (TRPV1; rs222749), which were screened from 74 pain-related SNPs. These SNPs, which were identified as being significantly associated with the analgesic effect of morphine, were then used to genotype the 135 patients in the RELIEF study who had been randomized into a morphine group (n=69) or an oxycodone group (n=66). The present study then assessed whether the SNPs could also be used as selective biomarkers to predict which opioid(s) might be the most suitable to provide pain relief for patients with cancer. Oxycodone tended to provide superior analgesic effects over morphine in patients carrying the genotype AA for the CCL11 rs17809012 SNP (P=0.012 for interaction), suggesting that it could serve as a potential biomarker for personalized analgesic therapy for patients suffering with cancer pain.

Schlagwörter

Stichwörter der Autor:innen

CCL11SNPcancer paingenotypemorphineoxycodone

Autor:innen und Institutionen

  • Department of Genome Biology, Kindai University Faculty of Medicine, Osaka 589-8511, Japan.
  • Department of Psychosomatic Medicine, Kindai University Faculty of Medicine, Osaka 589-8511, Japan.
  • Palliative Care Center, Kindai Hospital, Osaka 589-8511, Japan.
  • Palliative Care Team, National Cancer Center, Tokyo 104-0045, Japan.
  • Department of Biostatics, Kindai University Faculty of Medicine, Osaka 589-8511, Japan.
  • Advanced Cancer Translational Research Institute, Showa University, Tokyo 142-8555, Japan.

Zitieren

APA

Fujita, Y., Matsuoka, H., Chiba, Y., Tsurutani, J., Yoshida, T., Sakai, K., Nakura, M., Sakamoto, R., Makimura, C., Ohtake, Y., Tanaka, K., Hayashi, H., Takeda, M., Okuno, T., Takegawa, N., Haratani, K., Takahama, T., Tanizaki, J., Koyama, A., …, & Nakagawa, K. (2023). Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain. Oncology Letters, 26(2). https://doi.org/10.3892/ol.2023.13941

Vancouver

Fujita Y, Matsuoka H, Chiba Y, Tsurutani J, Yoshida T, Sakai K, et al. Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain. Oncology Letters. 2023;26(2). doi:10.3892/ol.2023.13941

BibTeX
@article{Fujita2023,
  author = {Fujita, Yoshihiko and Matsuoka, Hiromichi and Chiba, Yasutaka and Tsurutani, Junji and Yoshida, Takeshi and Sakai, Kiyohiro and Nakura, Miki and Sakamoto, Ryo and Makimura, Chihiro and Ohtake, Yoichi and Tanaka, Kaoru and Hayashi, Hidetoshi and Takeda, Masayuki and Okuno, Tatsuya and Takegawa, Naoki and Haratani, Koji and Takahama, Takayuki and Tanizaki, Junko and Koyama, Atsuko and Nishio, Kazuto and Nakagawa, Kazuhiko},
  title = {Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain},
  journal = {Oncology Letters},
  year = {2023},
  volume = {26},
  number = {2},
  doi = {10.3892/ol.2023.13941}
}
Kostenlos starten →